EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epidural analgesia during esophagectomy and esophageal cancer prognosis: A population‐based nationwide study in Finland

Pia H Petäjäkangas iD, Olli Helminen, Mika Helmiö, Heikki Huhta, Raija Kallio, Vesa Koivukangas, Arto Kokkola, Simo Laine, Elina Lietzen, Sanna Meriläinen, Vesa-Matti Pohjanen, Tuomo Rantanen und 8 weitere

Acta Anaesthesiologica Scandinavica · 2025

DOI: 10.1111/aas.70016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2025. Verfasst von Pia H Petäjäkangas und 19 weiteren Autor:innen. Beteiligte Einrichtung: Surgery Research Unit, Oulu University Hospital and University of Oulu, Oulu, Finland. Hauptthemen laut MEDLINE: Esophagectomy, Analgesia, Epidural, Esophageal Neoplasms. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Orionin Tutkimussäätiö, Sigrid Juséliuksen Säätiö, Finnish Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The use of epidural analgesia has been proposed to improve the prognosis of esophageal cancer by attenuating the stress response and being less immunosuppressive than opioids. This study aims to evaluate the association, if any, between non‐epidural pain management compared to epidural analgesia during minimally invasive or open esophagectomy and esophageal cancer prognosis. Materials and Methods This was a population‐based nationwide retrospective cohort study in Finland, using the Finnish National Esophago‐Gastric Cancer Cohort (FINEGO). Esophagectomy patients with epidural and no epidural analgesia were compared. Multivariable Cox regression provided hazard ratios (HR) with 95% confidence intervals (CI) non‐epidural pain management compared to epidural analgesia, adjusted for the calendar period of surgery, sex, age, comorbidity (Charlson Comorbidity Index), tumor stage, tumor histology, neoadjuvant therapy, type of surgery, and esophageal cancer surgery volume.

Results

After exclusions, there were 1381 patients available with information on epidural analgesia. Of these, 969 (70.2%) were men and 832 (60.2%) had esophageal adenocarcinoma. After adjustment for confounding factors, non‐epidural pain management was not associated with higher 90‐day mortality (HR 1.022 95% CI 0.582–1.794), overall mortality up to 5 years (HR 1.156 95% CI 0.909–1.470), nor with 5 years cancer‐specific mortality (HR 1.134 95% CI 0.884–1.456) compared to epidural analgesia.

Conclusion

Although the point estimates may hint at a potentially improved prognosis associated with epidural use, this population‐based nationwide study suggests no statistically significant association between epidural analgesia during esophagectomy and esophageal cancer prognosis. Editorial Comment This large esophagectomy (cancer) cohort in Finland was used to compare those who received epidural analgesia with those who did not for associations with late mortality in a retrospective analysis and where anesthesia and analgesia treatments were not controlled. The findings showed that when other recognized risks for mortality were taken into account, there was not a meaningful difference in relative risk for late mortality related to the presence or absence of epidural analgesia, though the analgesia treatments were not randomly allocated. These results do not rule out associations of analgesia choice with other outcomes that might be important to patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EsophagectomyAnalgesia, EpiduralEsophageal NeoplasmsHumansMaleFemaleFinlandRetrospective StudiesMiddle AgedAgedPrognosisCohort StudiesPain Management

Stichwörter der Autor:innen

epidural analgesiaesophageal canceresophagectomymortalityprognosis

Autor:innen und Institutionen

  • Surgery Research Unit, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • The Division of Digestive Surgery and Urology, Turku University Hospital and University of Turku, Turku, Finland.
  • Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland.
  • Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.
  • Department of Surgery, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.

ORCID-Profile: Pia H Petäjäkangas

Förderung

  • Orionin Tutkimussäätiö
  • Sigrid Juséliuksen Säätiö
  • Finnish Cancer Institute
  • Päivikki ja Sakari Sohlbergin Säätiö

Zitieren

APA

Petäjäkangas, P. H., Helminen, O., Helmiö, M., Huhta, H., Kallio, R., Koivukangas, V., Kokkola, A., Laine, S., Lietzen, E., Meriläinen, S., Pohjanen, V. M., Rantanen, T., Ristimäki, A., Räsänen, J. V., Saarnio, J., Sihvo, E., Toikkanen, V., Tyrväinen, T., Valtola, A., & Kauppila, J. H. (2025). Epidural analgesia during esophagectomy and esophageal cancer prognosis: A population‐based nationwide study in Finland. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.70016

Vancouver

Petäjäkangas PH, Helminen O, Helmiö M, Huhta H, Kallio R, Koivukangas V, et al. Epidural analgesia during esophagectomy and esophageal cancer prognosis: A population‐based nationwide study in Finland. Acta Anaesthesiologica Scandinavica. 2025. doi:10.1111/aas.70016

BibTeX
@article{Petjkangas2025,
  author = {Petäjäkangas, Pia H and Helminen, Olli and Helmiö, Mika and Huhta, Heikki and Kallio, Raija and Koivukangas, Vesa and Kokkola, Arto and Laine, Simo and Lietzen, Elina and Meriläinen, Sanna and Pohjanen, Vesa-Matti and Rantanen, Tuomo and Ristimäki, Ari and Räsänen, Jari V and Saarnio, Juha and Sihvo, Eero and Toikkanen, Vesa and Tyrväinen, Tuula and Valtola, Antti and Kauppila, Joonas H},
  title = {Epidural analgesia during esophagectomy and esophageal cancer prognosis: A population‐based nationwide study in Finland},
  journal = {Acta Anaesthesiologica Scandinavica},
  year = {2025},
  doi = {10.1111/aas.70016}
}
Kostenlos starten →